Bronchoscopic drainage with full personal protective equipment (PPE) saved a life of COVID-19 infected patient with ventilator associated pneumonic athelectasis from the Diamond Princess Cruise Ship

Yoshihiro Miyashita; Gaku Matsumoto; Yumiko Kakizaki; Toshiharu Tsutsui; Junichi Inoue; Masao Omata

doi:10.5430/crim.v7n4p1

Case Reports in Internal Medicine ›› 2020, Vol. 7 ›› Issue (4) :1 -4. DOI: 10.5430/crim.v7n4p1

CASE REPORTS

research-article

Bronchoscopic drainage with full personal protective equipment (PPE) saved a life of COVID-19 infected patient with ventilator associated pneumonic athelectasis from the Diamond Princess Cruise Ship

Author information +

History +

PDF (497KB)

Abstract

A 75 year-old American passenger was transferred to our hospital, infected in Diamond Princess, with pneumonia due to COVID-19 infection. At the beginning, he walked in but on day 4, he needed intubation and mechanical ventilation support because of worsening respiratory function due to wide-spread pneumonia. Despite the ventilation, his respiratory condition did not improve due to his left lower lobe atelectasis by an obstruction of left main bronchus. On day 9, interventional drainage of the major bronchus by disposable bronchoscopy was performed and built-up cast was removed by suctioning under the endoscopy. After the procedure, respiratory condition remarkably improved and he was extubated on day 14. COVID-19 infection with severe acute respiratory failure need mechanical ventilation support and if major airway obstruction was suspected, immediate interventional drainage may drastically change the patient clinical course and outcome.

Keywords

COVID-19 / Diamond Princess / Drainage / Bronchoscopy

Cite this article

Download citation ▾

Yoshihiro Miyashita, Gaku Matsumoto, Yumiko Kakizaki, Toshiharu Tsutsui, Junichi Inoue, Masao Omata. Bronchoscopic drainage with full personal protective equipment (PPE) saved a life of COVID-19 infected patient with ventilator associated pneumonic athelectasis from the Diamond Princess Cruise Ship. Case Reports in Internal Medicine, 2020, 7(4): 1-4 DOI:10.5430/crim.v7n4p1

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Guan W, Ni Z, Hu Y, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020; 382: 1708-1720.

[2]	Cao B, Wang Y, Wen D, et al. A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19. N Engl J Med. 2020; 382: 1787-1799. PMid:32187464. https://doi.org/10.1056/NEJMoa2001282

[3]	Grein J, Ohmagari N, Shin D, et al. Compassionate Use of Remdesivir for Patients with Severe Covid-19. N Engl J Med. 2020; 382(24): 1-10. PMid:32275812. https://doi.org/10.1056/NEJMoa2007016

[4]	Cai Q, Yang M, Liu D, et al. Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study. Engineering (Beijing). 2020 March. https://doi.org/10.1016/j.eng.2020.03.007

[5]	Lentz RJ, Colt H. Summarizing societal guidelines regarding bronchoscopy during the COVID-19 pandemic. Respirology. 2020 June; 25(6): 574-577. PMid:32277733. https://doi.org/10.29245/2572.942X/2016/4.1040

[6]

Menter T, Haslbauer JD, Nienhold R, et al. Post-morten Examination of COVID19 Patients Reveals Diffuse Alveolar Damage With Severe Capilllary Congestion and Variegated Findings of Lungs and Othed Organs Suggesting Vascular Dysfunction. Histopathology. 2020; 77(2): 198-209. PMid:32364264. https://doi.org/10.1111/his.14134